President Donald Trump has publicly stated that he asked 17 major drugmakers to take steps to cut U.S. Drug prices within 60 days.
Trump says he has asked drugmakers to cut US prices of drugs in 60 days.

Fact-checking Trump's claim that prescription drug price drops could happen 'almost immediately'
Source: pbs.org
Key Evidence
President Trump publicly stated on July 31, 2025, that he asked 17 drugmakers to take steps to cut U.S. Drug prices within 60 days.
cnbc.comcnbc.comTrump says he asked 17 drugmakers to take steps to cut U.S. prices within 60...
nbcnewyork.comnbcnewyork.comTrump says he asked drugmakers to take steps to cut U.S. prices within 60 days This is consistent with his administration's broader efforts including executive orders and tariffs aimed at reducing prescription drug costs.
whitehouse.govwhitehouse.govFact Sheet: President Donald J. Trump Announces Actions to Lower Prescription...
whitehouse.govwhitehouse.govFact Sheet: President Donald J. Trump Announces Actions to Put American Patients...
pbs.orgpbs.orgWATCH: Trump says he’ll set 30-day deadline for drugmakers to lower prescription...
reuters.comreuters.comTrump executive order demands pharma industry price cuts
What the Evidence Shows
As of July 31, 2025, President Donald Trump, the current sitting U.S. President, has made announcements and taken executive actions aimed at lowering prescription drug prices in the United States. Multiple credible news sources report that Trump sent letters to 17 pharmaceutical companies, including major firms like Eli Lilly, Pfizer, and Merck, requesting that they take steps to reduce drug prices within a 60-day timeframe.
This initiative is part of a broader policy effort by the Trump administration to address high drug costs through measures such as importation programs, tariffs on medicines from Europe, and executive orders aimed at aligning U.S. Drug prices with those paid in other countries. Earlier in 2025, Trump also set a 30-day deadline for drugmakers to lower prices as part of an executive order, indicating ongoing pressure on the pharmaceutical industry to reduce costs.
These actions are well-documented by reputable sources including CNBC, NBC New York, PBS NewsHour, Reuters, and official White House fact sheets.